These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 25884995)
1. Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy. Webber EM; Kauffman TL; O'Connor E; Goddard KA BMC Cancer; 2015 Mar; 15():156. PubMed ID: 25884995 [TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability: a predictive marker in metastatic colorectal cancer? Des Guetz G; Uzzan B; Nicolas P; Schischmanoff O; Morere JF Target Oncol; 2009 Jan; 4(1):57-62. PubMed ID: 19343302 [TBL] [Abstract][Full Text] [Related]
3. 5-fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer. Warusavitarne J; Ramanathan P; Kaufman A; Robinson BG; Schnitzler M Int J Colorectal Dis; 2006 Oct; 21(7):625-31. PubMed ID: 16557375 [TBL] [Abstract][Full Text] [Related]
4. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Des Guetz G; Schischmanoff O; Nicolas P; Perret GY; Morere JF; Uzzan B Eur J Cancer; 2009 Jul; 45(10):1890-6. PubMed ID: 19427194 [TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208 [TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis. Des Guetz G; Uzzan B; Nicolas P; Schischmanoff O; Perret GY; Morere JF Anticancer Res; 2009 May; 29(5):1615-20. PubMed ID: 19443375 [TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability and sensitivity to fluoropyrimidine and oxaliplatin containing first-line chemotherapy in metastatic colorectal cancer. Liu J; Wang B; Fang W Eur J Hosp Pharm; 2020 Sep; 27(5):267-270. PubMed ID: 32839257 [TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma. Srdjan M; Jadranka A; Ivan D; Branimir Z; Daniela B; Petar S; Velimir M; Zoran K Indian J Med Res; 2016 May; 143(Supplement):S104-S111. PubMed ID: 27748284 [TBL] [Abstract][Full Text] [Related]
10. Determination of microsatellite instability, p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: relationship with response to 5-fluorouracil and survival. Rosty C; Chazal M; Etienne MC; Letoublon C; Bourgeon A; Delpero JR; Pezet D; Beaune P; Laurent-Puig P; Milano G Int J Cancer; 2001 May; 95(3):162-7. PubMed ID: 11307149 [TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. Warusavitarne J; Schnitzler M Int J Colorectal Dis; 2007 Jul; 22(7):739-48. PubMed ID: 17109103 [TBL] [Abstract][Full Text] [Related]
12. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis. Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis. Wankhede D; Yuan T; Kloor M; Halama N; Brenner H; Hoffmeister M Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):609-619. PubMed ID: 38734024 [TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of tumour microsatellite-instability status as a predictor of response to fluorouracil-based adjuvant chemotherapy in colorectal cancer. Aggarwal N; Quaglia A; McPhail MJW; Monahan KJ Int J Colorectal Dis; 2022 Jan; 37(1):35-46. PubMed ID: 34677685 [TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and colorectal cancer prognosis. Benatti P; Gafà R; Barana D; Marino M; Scarselli A; Pedroni M; Maestri I; Guerzoni L; Roncucci L; Menigatti M; Roncari B; Maffei S; Rossi G; Ponti G; Santini A; Losi L; Di Gregorio C; Oliani C; Ponz de Leon M; Lanza G Clin Cancer Res; 2005 Dec; 11(23):8332-40. PubMed ID: 16322293 [TBL] [Abstract][Full Text] [Related]
16. Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients. Johansen AFB; Kassentoft CG; Knudsen M; Laursen MB; Madsen AH; Iversen LH; Sunesen KG; Rasmussen MH; Andersen CL BMC Cancer; 2019 Oct; 19(1):971. PubMed ID: 31638937 [TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy. Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916 [TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma. Elsaleh H; Iacopetta B Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368 [TBL] [Abstract][Full Text] [Related]